Tj. Hoerger et al., Healthcare use among US women aged 45 and older: Total costs and costs forselected postmenopausal health risks, J WOMEN H G, 8(8), 1999, pp. 1077-1089
Citations number
25
Categorie Soggetti
Public Health & Health Care Science","General & Internal Medicine
The purpose of this study is to estimate the level of healthcare use and co
sts incurred by postmenopausal women overall and for these selected conditi
ons: cardiovascular disease, osteoporosis, breast cancer, and gynecological
cancers. National healthcare survey and discharge data were used to estima
te healthcare use by women aged 45 and older. Clinical Classification for H
ealth Policy Research (CCHPR) codes were used to identify patients whose pr
imary diagnosis or procedure corresponded with the selected conditions. Nat
ional weights were used to estimate resource use. Treatment costs were esti
mated using cost/charge ratios or the Medicare fee schedule to calculate co
sts for each individual procedure. Estimated total annual medical care trea
tment costs for women 45 and older were about $186 billion in 1997 dollars,
including about $60.4 billion for cardiovascular disease, $12.9 billion fo
r osteoporosis, and $5.0 billion for breast and gynecological cancers. For
each condition, estimated resource use and costs are reported for hospitali
zation, outpatient, nursing home, and home healthcare services. Resource us
e and costs are also reported by age and expected source of payment. The ec
onomic burden of disease for conditions commonly affecting postmenopausal w
omen is substantial. Prior research establishes that hormone replacement th
erapy (HRT) may be effective in reducing the burden of disease among women
who continue preventive therapy for many years, but few at-risk women do so
. New alternatives for prevention, such as selective estrogen receptor modu
lators (SERMs), may be effective in reducing the burden of disease among po
stmenopausal women.